東威科技(688700.SH):自主研發的MSAP移載式VCP設備目前已有不少訂單
格隆匯6月27日丨有投資者向東威科技(688700.SH)提問,“請問公司自主研發的高端半導體MVCP設備有哪裏客户?今年有訂單嗎?能否帶來業績進一步提升,現在有哪些項目產線在建,能否介紹一下。”
東威科技回覆稱,公司自主研發的MSAP移載式VCP設備主要用在芯片、顯示屏等IC載板的電鍍工藝上,與公司傳統的PCB業務的客户羣體存在重疊,目前已有不少訂單,未來會在業績中體現出來,且隨着量的增加,該設備業績的比重將逐步提升。具體情況請關注公司公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.